 |
 |

Injectable Calcium Hydroxyapatite Filler for Minimally Invasive Delayed Treatment of Traumatic Enophthalmos
Reem Z. Renno, MD
Arch Facial Plast Surg. 2007;9(1):62-63.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
INTRODUCTION
Enophthalmos of 2 mm or more is aesthetically unacceptable and usually requires surgical intervention. For complex orbitofacial fractures with ocular retrusion, combined modalities such as reduction of the herniated content, osteotomy, fixation of fracture, and placement of onlay graft to support the orbital structures and to correct enophthalmos are usually necessary.1 However, in cases in which loss of volume is not associated with fracture, volume augmentation alone can be performed through placement of autogenous tissues and alloplastic materials such as blocks, sheets, beads, and injectable forms.2-8
Radiesse (BioForm Medical Inc, San Mateo, Calif) is an injectable implant consisting of small particles of calcium hydroxylapatite (microspheres 25-45 µm in diameter) suspended in an aqueous gel carrier. It has been used for years for vocal cord and bladder dysfunction and has a long-lasting effect (1-1 years). It has also been used for soft tissue augmentation as part of . . . [Full Text of this Article]
REPORT OF A CASE
COMMENT
AUTHOR INFORMATION
|